{"clinical_assertion_trait_set_id":"SCV001366606","interpretation_description":"Pathogenic","local_key":"NM_005957.4:c.665C\u003eT|HPO:HP:0000160;HP:0000219;HP:0000347;HP:0000711;HP:0000729;HP:0000750;HP:0001939;HP:0002024;HP:0003287;HP:0007525;HP:0012736","submitted_assembly":"GRCh37","submission_id":"505952.2020-04-08","variation_archive_id":"VCV000003520","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG guidelines, Richards 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"30311386\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":["{\"text\":\"This variant was classified as: Uncertain significance. The available evidence on this varinat's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: BP4. This variant was detected in heterozygous state.\"}"],"interpretation_date_last_evaluated":"2019-04-23","id":"SCV001366606","date_created":"2020-07-01","assertion_type":"variation to disease","submitter_id":"505952","internal_id":"2694687","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-06","clinical_assertion_observation_ids":["SCV001366606.0"],"variation_id":"3520","submission_names":["SUB7240337"],"version":"1"}
{"clinical_assertion_trait_set_id":"SCV001368806","interpretation_description":"Pathogenic","local_key":"NM_005957.4:c.665C\u003eT|HPO:HP:0005765","submitted_assembly":"GRCh37","submission_id":"505952.2020-04-08","variation_archive_id":"VCV000003520","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG guidelines, Richards 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"30311386\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":["{\"text\":\"This variant was classified as: Uncertain significance. The available evidence on this varinat's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM1,PM2,PP3,BP1. This variant was detected in heterozygous state.\"}"],"interpretation_date_last_evaluated":"2019-06-20","id":"SCV001368806","date_created":"2020-07-01","assertion_type":"variation to disease","submitter_id":"505952","trait_set_id":"54912","internal_id":"2696892","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-06","clinical_assertion_observation_ids":["SCV001368806.0"],"rcv_accession_id":"RCV001198021","variation_id":"3520","submission_names":["SUB7240337"],"version":"1"}
{"clinical_assertion_trait_set_id":"SCV001147149","interpretation_description":"Uncertain significance","local_key":"95|MedGen:CN517202","submitted_assembly":"GRCh37","submission_id":"505870.2020-07-06","variation_archive_id":"VCV000003520","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","interpretation_comments":[],"interpretation_date_last_evaluated":"2016-10-01","id":"SCV001147149","date_created":"2020-01-30","assertion_type":"variation to disease","submitter_id":"505870","trait_set_id":"9460","internal_id":"2265337","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-11","clinical_assertion_observation_ids":["SCV001147149.0"],"rcv_accession_id":"RCV000153516","variation_id":"3520","submission_names":["2020-07"],"version":"4"}
{"clinical_assertion_trait_set_id":"SCV001366354","interpretation_description":"Pathogenic","local_key":"NM_005957.4:c.665C\u003eT|HPO:HP:0002160","submitted_assembly":"GRCh37","submission_id":"505952.2020-04-08","variation_archive_id":"VCV000003520","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG guidelines, Richards 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"30311386\",\"@Source\":\"PubMed\"}}}}","interpretation_comments":["{\"text\":\"This variant was classified as: Uncertain significance. The available evidence on this varinat's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. This variant was detected in heterozygous state.\"}"],"interpretation_date_last_evaluated":"2019-01-17","id":"SCV001366354","date_created":"2020-07-01","assertion_type":"variation to disease","submitter_id":"505952","trait_set_id":"54182","internal_id":"2694435","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-06","clinical_assertion_observation_ids":["SCV001366354.0"],"rcv_accession_id":"RCV001195930","variation_id":"3520","submission_names":["SUB7240337"],"version":"1"}
{"clinical_assertion_trait_set_id":"SCV001147323","interpretation_description":"Uncertain significance","local_key":"1866|MedGen:CN517202","submitted_assembly":"GRCh37","submission_id":"505870.2020-07-06","variation_archive_id":"VCV000007884","record_status":"current","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","interpretation_comments":[],"interpretation_date_last_evaluated":"2019-11-01","id":"SCV001147323","date_created":"2020-01-30","assertion_type":"variation to disease","submitter_id":"505870","trait_set_id":"9460","internal_id":"2265511","review_status":"criteria provided, single submitter","date_last_updated":"2020-07-11","clinical_assertion_observation_ids":["SCV001147323.0"],"rcv_accession_id":"RCV000078671","variation_id":"7884","submission_names":["2020-07"],"version":"4"}
